| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 156,601 | 147,759 | 150,770 | 188,219 | | Cost of Revenue | 134,125 | 126,721 | 127,357 | 159,709 | | | Gross Profit | 22,476 | 21,038 | 23,413 | 28,510 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 22,852 | 21,693 | 26,933 | 28,653 | | Non Recurring |
-
|
-
| 7,443 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (376) | (655) | (10,963) | (143) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7 | 3 | 89 | 7 | | Earnings Before Interest And Taxes | (369) | (652) | (10,874) | (136) | | Interest Expense | 271 | 422 | 578 | 747 | | Income Before Tax | (640) | (1,074) | (11,452) | (883) | | Income Tax Expense | (1,253) | (161) | (686) | (1,127) | | Minority Interest | (70) | (31) | 34 | (94) | | | | Net Income From Continuing Ops | 543 | (944) | (10,732) | 150 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 543 | (944) | (10,732) | 150 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $543 | ($944) | ($10,732) | $150 |
|
0.51% Nasdaq 
Income Statement
